Vienna - Delayed Quote EUR

SYNLAB AG (SYAB.VI)

10.52 0.00 (0.00%)
At close: 5:32 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Mathieu Floreani Chairman of the Management Board & CEO 2.39M -- 1967
Dr. Bartholomäus Wimmer Founder & Independent Member of the Supervisory Board 132k -- 1962
Mr. Sami Badarani CFO & Member of Management Board 1.5M -- 1963
Mr. Robert Steinwander Group Chief Operating Officer -- -- --
Mr. Henrik Andreasen Group Chief Information Officer -- -- --
Dr. Anna Niedl Head of Investor Relations -- -- --
Ms. Kimberly Urdahl Group General Counsel & Group Chief Compliance Officer -- -- --
Alexander Hagen Group Head of Commercial & Marketing -- -- --
Ms. Catharina Monster Group Chief Human Resources Officer -- -- --
Mr. Luis Vieira Group Chief Strategy Officer -- -- --

SYNLAB AG

Moosacher Straße 88
Munich, 80809
Germany
49 89 307602 0 https://www.synlab.com
Sector: 
Healthcare
Full Time Employees: 
23,538

Description

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

Corporate Governance

SYNLAB AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Aug 23, 1970
    Dividend Date

Upcoming Events